Co-Authors
This is a "connection" page, showing publications co-authored by RICHARD E CHAMPLIN and JEFFREY J TARRAND.
Connection Strength
0.522
-
The characteristics and outcomes of parainfluenza virus infections in 200 patients with leukemia or recipients of hematopoietic stem cell transplantation. Blood. 2012 Mar 22; 119(12):2738-45; quiz 2969.
Score: 0.107
-
Development and validation of a risk assessment tool for BKPyV Replication in allogeneic stem cell transplant recipients. Transpl Infect Dis. 2020 Oct; 22(5):e13395.
Score: 0.048
-
Control of nosocomial Clostridium difficile transmission in bone marrow transplant patients. Infect Control Hosp Epidemiol. 2000 Mar; 21(3):226-8.
Score: 0.047
-
Poor immune reconstitution is associated with symptomatic BK polyomavirus viruria in allogeneic stem cell transplant recipients. Transpl Infect Dis. 2017 Feb; 19(1).
Score: 0.038
-
Symptomatic BK Virus Infection Is Associated With Kidney Function Decline and Poor Overall Survival in Allogeneic Hematopoietic Stem Cell Recipients. Am J Transplant. 2016 05; 16(5):1492-502.
Score: 0.036
-
Ganciclovir three times per week is not adequate to prevent cytomegalovirus reactivation after T cell-depleted marrow transplantation. Bone Marrow Transplant. 1994 Apr; 13(4):461-4.
Score: 0.031
-
Impact of aerosolized ribavirin on mortality in 280 allogeneic haematopoietic stem cell transplant recipients with respiratory syncytial virus infections. J Antimicrob Chemother. 2013 Aug; 68(8):1872-80.
Score: 0.029
-
Adenoviral infections in adult allogeneic hematopoietic SCT recipients: a single center experience. Bone Marrow Transplant. 2013 Sep; 48(9):1218-23.
Score: 0.029
-
Hemorrhagic cystitis after allogeneic hematopoietic stem cell transplants is the complex result of BK virus infection, preparative regimen intensity and donor type. Haematologica. 2010 Jul; 95(7):1183-90.
Score: 0.024
-
Detection and control of a nosocomial respiratory syncytial virus outbreak in a stem cell transplantation unit: the role of palivizumab. Biol Blood Marrow Transplant. 2010 Sep; 16(9):1265-71.
Score: 0.024
-
Microbial contamination of hematopoietic progenitor cell products: clinical outcome. Bone Marrow Transplant. 2007 Aug; 40(4):365-8.
Score: 0.019
-
Respiratory viral infections in adults with hematologic malignancies and human stem cell transplantation recipients: a retrospective study at a major cancer center. Medicine (Baltimore). 2006 Sep; 85(5):278-287.
Score: 0.018
-
Cytomegalovirus pneumonia in adult autologous blood and marrow transplant recipients. Bone Marrow Transplant. 2001 Apr; 27(8):877-81.
Score: 0.013
-
Late cytomegalovirus pneumonia in adult allogeneic blood and marrow transplant recipients. Clin Infect Dis. 1999 Mar; 28(3):618-23.
Score: 0.011
-
Transfusion support using filtered unscreened blood products for cytomegalovirus-negative allogeneic marrow transplant recipients. Bone Marrow Transplant. 1998 Sep; 22(6):575-7.
Score: 0.011
-
Common emergence of amantadine- and rimantadine-resistant influenza A viruses in symptomatic immunocompromised adults. Clin Infect Dis. 1998 Jun; 26(6):1418-24.
Score: 0.010
-
Nosocomial respiratory syncytial virus infections: prevention and control in bone marrow transplant patients. Infect Control Hosp Epidemiol. 1997 Jun; 18(6):412-6.
Score: 0.010
-
Comparison of cytomegalovirus antigenemia and shell vial culture in allogeneic marrow transplantation recipients receiving ganciclovir prophylaxis. Bone Marrow Transplant. 1997 Jan; 19(1):37-41.
Score: 0.009
-
Community respiratory virus infections among hospitalized adult bone marrow transplant recipients. Clin Infect Dis. 1996 May; 22(5):778-82.
Score: 0.009